Recon Onkos Surgical® Successfully Completes Groundbreaking, First-in-Human Cases Using NanoCept™ Antibacterial Technology byTim AllenJanuary 9, 2025
Biologics Regulatory MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants byJosh SandbergJune 20, 2024
Recon Regulatory Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants byJosh SandbergApril 8, 2024
Biologics Regulatory Top Stories SINTX Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio byJosh SandbergOctober 4, 2022
Biologics Scientists develop technology to produce bioactive coating with antibacterial effect byJosh SandbergMarch 31, 2016
